BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30963399)

  • 21. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
    Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
    Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of laparoscopic and open surgery following pre-operative chemoradiation therapy for locally advanced lower rectal cancer.
    Kusano T; Inomata M; Hiratsuka T; Akagi T; Ueda Y; Tojigamori M; Shiroshita H; Etoh T; Shiraishi N; Kitano S
    Jpn J Clin Oncol; 2014 Apr; 44(4):305-10. PubMed ID: 24596335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
    Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO
    Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer.
    De Nardi P; Testoni SG; Corsetti M; Andreoletti H; Giollo P; Passaretti S; Testoni PA
    Dig Liver Dis; 2017 Jan; 49(1):91-97. PubMed ID: 27720700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features and risk factors of surgical complications after intersphincteric resection for low rectal cancer following neoadjuvant chemoradiotherapy].
    Qin QY; Ma TH; Cai J; Huang XY; Wu YL; Wang HM; Wang H; Wang L
    Zhonghua Wai Ke Za Zhi; 2018 Dec; 56(12):892-899. PubMed ID: 30497115
    [No Abstract]   [Full Text] [Related]  

  • 30. Appropriate Timing of Surgery after Neoadjuvant ChemoRadiation Therapy for Locally Advanced Rectal Cancer.
    Garrer WY; El Hossieny HA; Gad ZS; Namour AE; Abo Amer SM
    Asian Pac J Cancer Prev; 2016; 17(9):4381-4389. PubMed ID: 27797248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transanal Endoscopic Microsurgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Issa N; Murninkas A; Schmilovitz-Weiss H; Agbarya A; Powsner E
    J Laparoendosc Adv Surg Tech A; 2015 Aug; 25(8):617-24. PubMed ID: 26258267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
    Fan J; Zhu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
    Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
    Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Sun Z; Adam MA; Kim J; Shenoi M; Migaly J; Mantyh CR
    J Am Coll Surg; 2016 Apr; 222(4):367-74. PubMed ID: 26897480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer on surgical and oncologic outcome.
    Zeng WG; Zhou ZX; Liang JW; Wang Z; Hou HR; Zhou HT; Zhang XM; Hu JJ
    J Surg Oncol; 2014 Sep; 110(4):463-7. PubMed ID: 24889826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
    Sloothaak DA; Geijsen DE; van Leersum NJ; Punt CJ; Buskens CJ; Bemelman WA; Tanis PJ;
    Br J Surg; 2013 Jun; 100(7):933-9. PubMed ID: 23536485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoradiotherapy with Concurrent Regional Arterial Chemotherapy for Locally Bulky Unresectable Rectal Cancer: A Case Series.
    Huang W; Wu J; Liu G; Lv Y; Huang J; Li W
    Oncol Res Treat; 2019; 42(12):678-683. PubMed ID: 31514189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The outcome of 5-fluorouracil chemotherapy after the completion of neoadjuvant chemoradiotherapy, administered until 2 weeks before rectal cancer resection.
    Chang PK; Chiang MH; Jao SW; Wu CC; Lee CC; Lee TY; Hsiao CW
    J Chin Med Assoc; 2015 Aug; 78(8):475-80. PubMed ID: 26144023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
    Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.